|
|
| Whitepaper: Nose to Brain (N2B) Drug Delivery – Benefits and Challenges. | The brain and central nervous system (CNS) are critical yet challenging targets for drug delivery due to barriers like the blood-brain barrier. Explore the benefits and challenges of Nose to Brain (N2B) delivery, including delivery targets, transport mechanisms, liquid and dry powder formulations, and the development of nasal dosage forms. Read more to discover strategies to overcome these obstacles for effective CNS treatments. |
|
|
|
Is CDMO Quality A Concern Today? | By Outsourced Pharma Live | Praveen Prasana from Verve Therapeutics, GenSight Biologics' Scott Jeffers, and Vaibhav Patel from the University of Minnesota discuss quality concerns at CDMOs. |
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Computerized Maintenance Management Systems (CMMS); Integrated Facilities Management (IFM); Mechanical / Electrical Systems (M&E); and pest control (!) ... who handles maintenance at your CDMO? Here's what you should know from someone who has been doing it for decades. |
|
|
|
|
|
|
|
Accelerate And De-Risk Bioconjugate Drug Development | Article | By Elisabeth Engelsberger, Ph.D. and Raphael Frey, Ph.D., Lonza | With a growing interest in developing new and improved bioconjugate drugs, explore an “innovation through collaboration” approach that can facilitate access to next-generation conjugation technologies. |
|
|
|
Leveraging Tools To Create Optimized Solutions | Q&A | Adare Pharma Solutions | Review the key trends and challenges shaping the CDMO industry as well as the tools helping a leading CDMO meet the growing demand for pediatric formulations and taste-masking solutions. |
|
|
|
|
PBPK Predictive Modeling Services | Lonza | Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program. |
|
|
Comprehensive Regulatory Support | Douglas CDMO | Review our expertise across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner. |
|
|
Capacity Update October 2024: Small Molecule | AbbVie | Watch this overview of our extensive capabilities, including a deep dive into our HPAPI and API services and the available capacity at our Campoverdi, Italy facility for your next project. |
|
|
Pharmaceutical Clinical Trial Distribution Services | Ropack Pharma Solutions | From its facilities in Montreal, Quebec, Ropack handles most paperwork, permissions, components, warehousing, packaging, distribution, collection, and destruction as a single project. |
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|